The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase IB Study of pembrolizumab (Pembro) and pegylated-interferon alfa-2b (Peg-IFN) in advanced melanoma (MEL).
 
Diwakar Davar
Stock and Other Ownership Interests - CTI; Horizon Pharma
 
Hong Wang
No Relationships to Disclose
 
Joe-Marc Chauvin
No Relationships to Disclose
 
Zhaojun Sun
No Relationships to Disclose
 
Ornella Pagliano
No Relationships to Disclose
 
Amy Rose
No Relationships to Disclose
 
Carrie Muniz
No Relationships to Disclose
 
Cindy Sander
No Relationships to Disclose
 
Julien J. Fourcade
No Relationships to Disclose
 
Uma N. M. Rao
No Relationships to Disclose
 
Nageatte Ibrahim
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Scot Ebbinghaus
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Hussein Abdul-Hassan Tawbi
No Relationships to Disclose
 
Ahmad A. Tarhini
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Merck Sharp & Dohme
Research Funding - Amgen; Bristol-Myers Squibb; Merck Sharp & Dohme; Novartis; Prometheus
 
John M. Kirkwood
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Genentech; GreenPeptide; Roche
Research Funding - Merck (Inst); Prometheus (Inst)
 
Hassane M. Zarour
Research Funding - Bristol-Myers Squibb
 
Giuseppe Russo
Employment - Merck
Stock and Other Ownership Interests - Merck